Trial Profile
Pilot Study: Iron-chelating treatment in patients with Neurodegeneration with Brain Iron Accumulation (NBIA).
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Aug 2011
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary)
- Indications Neurodegenerative disorders
- Focus Therapeutic Use
- 02 Aug 2011 New trial record